SNDX - Syndax Pharmaceuticals

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by StockJock-e, May 17, 2017.

Tags:
  1. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,545
    Likes Received:
    3,544
    Developing a therapy that enhances checkpoint immuno-oncology drugs.

    [​IMG]
     
    #1 StockJock-e, May 17, 2017
  2. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,545
    Likes Received:
    3,544
    Todays news:

    Shares of Syndax Pharmaceuticals Inc. (SNDX) saw a huge gain on Wednesday after the firm gave an update on its non-small cell lung cancer (NSCLC) midstage trial. Specifically, the company announced that Encore 601 has met the prespecified objective response threshold to advance into the second stage of the Phase 2 trial and will reopen enrollment immediately
     
    #2 StockJock-e, May 17, 2017
(You must log in or sign up to post here.)

Share This Page